US Equities insigtX

Former Israeli National Security Advisor Joins SciSparc Scientific Advisory Board

The appointment of the former Chairman of Israel's National Security Council and acting National Security Advisor to former Prime Minister Benjamin Netanyahu marks another step in SciSparc's efforts…

Published
Market
US Equities
Source
insigtX

The appointment of the former Chairman of Israel's National Security Council and acting National Security Advisor to former Prime Minister Benjamin Netanyahu marks another step in SciSparc's efforts to lay the scientific and strategic groundwork for its planned foray into the Agentic AI space

TEL AVIV, Israel, November 16, 2026 — SciSparc Ltd. today announced the appointment of Professor Jacob Nagel to the Company's Artificial Intelligence and Cyber Security Scientific Advisory Board. Professor Nagel is a renowned expert in technology and national security with extensive experience in artificial intelligence, advanced technologies, and cybersecurity. This appointment marks another step in SciSparc's efforts to establish a scientific and strategic foundation for its planned entry into the evolving Agentic AI field.

Following the Company's previously announced decision to explore opportunities in this field, SciSparc is moving to put its plans into action by establishing a network of leading scientific and technological experts to support its evaluation of potential technologies, strategic partnerships, and opportunities.

Professor Nagel brings decades of experience at the intersection of advanced technologies, artificial intelligence, cybersecurity, defense innovation, and strategic decision-making. Professor Nagel is a visiting professor at the Technion – Israel Institute of Technology, where he heads the Institute's Center for Security, Science and Technology. He served as Chairman of Israel's National Security Council and acting National Security Advisor to former Prime Minister Benjamin Netanyahu from 2016 to 2017. Previously, he held senior positions at the Israeli Ministry of Defense, including serving as Scientific Deputy and Acting Director of the Directorate of Defense Research & Development. He also served for 16 years as a technological expert in Israel's national signals intelligence unit.

In 2025, Professor Nagel chaired Israel's national committee for accelerating the field of artificial intelligence, which issued recommendations aimed at strengthening Israel's position in the global AI landscape, covering areas such as AI infrastructure, computing power, research, human capital, and a national AI strategy. His extensive experience in AI, emerging technologies, cybersecurity, and national-level technology strategy is expected to provide valuable perspectives for SciSparc's evaluation of the evolving Agentic AI ecosystem and potential opportunities for entry into the field.

This appointment follows SciSparc's recent addition of Professor Carmel Domshlak to the Company's Scientific Advisory Board. Professor Domshlak is an internationally recognized AI expert and a professor at the Technion – Israel Institute of Technology. Professor Domshlak possesses deep expertise in intelligent autonomous behavior, automated reasoning, action planning, sequential decision-making, and multi-agent systems.

About SciSparc Ltd.: SciSparc Ltd. is undergoing a strategic transformation toward Agentic AI-driven technologies, with a focus on applications in the cybersecurity and financial sectors. Following its decision to target the Agentic AI market and the establishment of its AI and Cyber Security Scientific Advisory Board, the Company is evaluating technologies, companies, and business opportunities within the Agentic AI ecosystem. Agentic AI refers to AI systems designed to autonomously plan and execute tasks to achieve defined goals. In parallel, through its subsidiary NeuroThera Labs Inc., SciSparc continues to advance its clinical-stage cannabinoid drug programs, including SCI-110 for the treatment of Tourette syndrome and agitation associated with Alzheimer's disease, and SCI-210 for the treatment of autism spectrum disorder and status epilepticus. NeuroThera also holds a controlling interest in a subsidiary that sells hemp seed oil products on Amazon.com.

Forward-Looking Statements: This press release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995 and other federal securities laws. For example, SciSparc is using forward-looking statements when it discusses moving quickly to put its plans into action by establishing a network of leading scientific and technological experts to support its evaluation of potential technologies, strategic partnerships, and opportunities, and its evaluation of the evolving Agentic AI ecosystem and potential opportunities to enter the field. Because such statements deal with future events and are based on SciSparc's current expectations, they are subject to various risks and uncertainties, and SciSparc's actual results, performance, or achievements could differ materially from those described in or implied by the statements in this press release. The forward-looking statements contained or implied in this press release are also subject to other risks and uncertainties, including those discussed under the heading "Risk Factors" in SciSparc's Annual Report on Form 20-F, as amended, filed with the U.S. Securities and Exchange Commission on April 29, 2026, and in subsequent filings with the U.S. Securities and Exchange Commission. Except as otherwise required by law, SciSparc undertakes no intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, changes in circumstances, or otherwise, which speak only as of the date hereof.

Investor Contact: IR@scisparc.com Tel: +972-3-6167055

Original: https://www.globenewswire.com/news-release/2026/11/16/3403411/0/en/scisparc-former-national-security-advisor-to-prime-minister-benjamin-netanyahu-renowned-ai-prof-jacob-nagel-joins-the-company-s-sab.html

insigtX content is informational and educational, not investment advice.